Annexon

ANNXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$886.388 M

$5.41 -3.39%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$206.7M

Loss-making

Shares outstanding

149,362,800

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#169Amphastar PharmaceuticalsAMPH$916.3M
#170Arbutus BiopharmaABUS$914.6M
#171AnnexonANNX$886.4M
#172Design TherapeuticsDSGN$875.5M
#173Theravance BiopharmaTBPH$872.8M

Where these numbers come from

Share counts and financials for Annexon are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.